retatrutide triple hormone receptor agonist obesity A review of an investigational drug retatrutide, a novel agent for the treatment of retatrutide obesity triple hormone receptor
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13

























